UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Secukinumab versus adalimumab for treatment of active psoriatic arthritis (EXCEED): a double-blind, parallel-group, randomised, active-controlled, phase 3b trial

The Lancet (British edition), 2020-05, Vol.395 (10235), p.1496-1505

2020

Volltextzugriff (PDF)

Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial

The Lancet (British edition), 2015-09, Vol.386 (9999), p.1137-1146

2015

Volltextzugriff (PDF)

Fibroblast activation and inflammation in frozen shoulder

PloS one, 2019-04, Vol.14 (4), p.e0215301-e0215301

2019

Volltextzugriff (PDF)

Efficacy and safety of secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind, placebo-controlled, phase II proof-of-concept trial

Annals of the rheumatic diseases, 2014-02, Vol.73 (2), p.349-356

2014

Volltextzugriff (PDF)

Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trial

Annals of the rheumatic diseases, 2014-06, Vol.73 (6), p.990-999

2014

Volltextzugriff (PDF)

Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies

The lancet. Diabetes & endocrinology, 2018-06, Vol.6 (6), p.464-475

2018

Volltextzugriff (PDF)

Targeting ultrasound remission in early rheumatoid arthritis: the results of the TaSER study, a randomised clinical trial

Annals of the rheumatic diseases, 2016-06, Vol.75 (6), p.1043-1050

2016

Volltextzugriff (PDF)

Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA)

Annals of the rheumatic diseases, 2014-01, Vol.73 (1), p.62-68

2014

Volltextzugriff (PDF)

Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study

The Lancet. Psychiatry, 2020-10, Vol.7 (10), p.875-882

2020

Volltextzugriff (PDF)

Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial

The Lancet (British edition), 2013-08, Vol.382 (9894), p.780-789

2013

Volltextzugriff (PDF)

Translational targeting of inflammation and fibrosis in frozen shoulder: Molecular dissection of the T cell/IL-17A axis

Proceedings of the National Academy of Sciences - PNAS, 2021-09, Vol.118 (39), p.1-11

2021

Volltextzugriff (PDF)

Exploring patterns of daily physical and sedentary behaviour in community-dwelling older adults

Age and ageing, 2011-03, Vol.40 (2), p.205-210

2011

Volltextzugriff (PDF)

Effect of amiloride, or amiloride plus hydrochlorothiazide, versus hydrochlorothiazide on glucose tolerance and blood pressure (PATHWAY-3): a parallel-group, double-blind randomised phase 4 trial

The lancet. Diabetes & endocrinology, 2016-02, Vol.4 (2), p.136-147

2016

Volltextzugriff (PDF)

Combination Therapy Is Superior to Sequential Monotherapy for the Initial Treatment of Hypertension: A Double‐Blind Randomized Controlled Trial

Journal of the American Heart Association, 2017-11, Vol.6 (11), p.n/a

2017

Volltextzugriff (PDF)

A Multicenter, Randomized, Placebo‐Controlled Trial of Atorvastatin for the Primary Prevention of Cardiovascular Events in Patients With Rheumatoid Arthritis

Arthritis & rheumatology (Hoboken, N.J.), 2019-09, Vol.71 (9), p.1437-1449

2019

Volltextzugriff (PDF)

Combination therapy with sulfasalazine and methotrexate is more effective than either drug alone in patients with rheumatoid arthritis with a suboptimal response to sulfasalazine: results from the double-blind placebo-controlled MASCOT study

Annals of the rheumatic diseases, 2007-02, Vol.66 (2), p.235-241

2007

Volltextzugriff (PDF)

Measuring disease progression in early Parkinson disease: the National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) experience

JAMA neurology, 2014-06, Vol.71 (6), p.710

2014

Volltextzugriff (PDF)

Lipoma arborescens co-existing with psoriatic arthritis releases tumour necrosis factor alpha and matrix metalloproteinase 3

Annals of the rheumatic diseases, 2010-04, Vol.69 (4), p.776-777

2010

Volltextzugriff (PDF)

A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease

Neurology, 2006-03, Vol.66 (5), p.664-671

2006

Volltextzugriff (PDF)

A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease

Neurology, 2007-01, Vol.68 (1), p.20

NINDS NET-PD Investigators

2007

Volltextzugriff (PDF)

Donor age and the frequency of disomy for chromosomes 1, 13, 21 and structural abnormalities in human spermatozoa using multicolour fluorescence in-situ hybridization

Human reproduction (Oxford), 1998-09, Vol.13 (9), p.2489-2494

1998

Volltextzugriff (PDF)

Long-term outcome of early versus delayed rasagiline treatment in early Parkinson's disease

Movement disorders, 2009-03, Vol.24 (4), p.564-573

2009

Volltextzugriff (PDF)

Testing for HIV and sexually transmissible infections within a mainly online sample of gay men who engage in group sex

Sexually transmitted infections, 2009-02, Vol.85 (1), p.70-74

2009

Volltextzugriff (PDF)

Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial

The Lancet. Rheumatology, 2024-06, Vol.6 (6), p.e339-e351

2024

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Aktive Filter

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(36)

Sprache

Englisch
(36)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Secukinumab versus adalimumab for treatment of active psoriatic arthritis (EXCEED): a double-blind, parallel-group, randomised, active-controlled, phase 3b trial

Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial

Fibroblast activation and inflammation in frozen shoulder

Efficacy and safety of secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind, placebo-controlled, phase II proof-of-concept trial

Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies

Targeting ultrasound remission in early rheumatoid arthritis: the results of the TaSER study, a randomised clinical trial

Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA)

Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry

Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study

Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial

Translational targeting of inflammation and fibrosis in frozen shoulder: Molecular dissection of the T cell/IL-17A axis

Exploring patterns of daily physical and sedentary behaviour in community-dwelling older adults

Effect of amiloride, or amiloride plus hydrochlorothiazide, versus hydrochlorothiazide on glucose tolerance and blood pressure (PATHWAY-3): a parallel-group, double-blind randomised phase 4 trial

Combination Therapy Is Superior to Sequential Monotherapy for the Initial Treatment of Hypertension: A Double‐Blind Randomized Controlled Trial

A Multicenter, Randomized, Placebo‐Controlled Trial of Atorvastatin for the Primary Prevention of Cardiovascular Events in Patients With Rheumatoid Arthritis

Combination therapy with sulfasalazine and methotrexate is more effective than either drug alone in patients with rheumatoid arthritis with a suboptimal response to sulfasalazine: results from the double-blind placebo-controlled MASCOT study

Measuring disease progression in early Parkinson disease: the National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) experience

Lipoma arborescens co-existing with psoriatic arthritis releases tumour necrosis factor alpha and matrix metalloproteinase 3

A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease

A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease

Donor age and the frequency of disomy for chromosomes 1, 13, 21 and structural abnormalities in human spermatozoa using multicolour fluorescence in-situ hybridization

Long-term outcome of early versus delayed rasagiline treatment in early Parkinson's disease

Testing for HIV and sexually transmissible infections within a mainly online sample of gay men who engage in group sex

Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial

Aktive Filter

Suchergebnisse filtern